日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

No Effects of Predictability on Word-Meaning Priming and Incidental Memory

可预测性对词义启动和偶然记忆没有影响

Keller, Vanessa G; Mak, Matthew H C; Cairney, Scott A; Gaskell, M Gareth

Memory consolidation during sleep: a facilitator of new learning?

睡眠期间的记忆巩固:促进新学习的因素?

Guttesen, Anna Á V; Harrington, Marcus O; Fleming, Melanie K; Gaskell, M Gareth; Cairney, Scott A

Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.

ANICCA-Class II 的最终结果是一项单臂、开放标签的 II 期试验,旨在评估 nivolumab 在组织特异性 II 类表达转移性微卫星稳定型结直肠癌中的疗效,同时平行评估免疫评分-免疫检查点作为单药抗 PD-1 的预测生物标志物。

Middleton Gary, Gaskell Charlotte, Savage Joshua, Bridgewater John, Ross Paul, Saunders Mark, Palmer Daniel, Plummer Ruth, Clive Sally, Coyle Vicky, Thomas Anne, Cunningham David, Taniere Phillipe, Billingham Lucinda

Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial

Fedratinib联合ropeginterferon alfa-2b治疗骨髓纤维化患者(FEDORA):一项多中心、开放标签、贝叶斯II期试验的研究方案

McIlroy, Graham; Gaskell, Charlotte; Jackson, Aimee; Yafai, Emily; Tasker, Rachel; Thomas, Catherine; Fox, Sonia; Boucher, Rebecca; Ghebretinsea, Fitsum; Harrison, Claire; Mead, Adam J; McMullin, Mary Frances

Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)

一项针对无关供体干细胞移植后移植物抗宿主病 (GvHD) 预防的多中心适应性随机试验,比较了胸腺球蛋白与基于钙调磷酸酶抑制剂或西罗莫司的移植后环磷酰胺(T 细胞清除方法,MoTD 试验)

Chakraverty, Ronjon; Kempshall, Emma; Dignan, Fiona; Bloor, Adrian; Collin, Matthew; Raj, Kavita; Davies, Jeff; Potter, Victoria; Malladi, Ram; Smith, Siobhan; Gates, Simon; Gaskell, Charlotte; Bishop, Rebecca; Hodgkinson, Andrea; Smith, Gabrielle

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial

Selumetinib联合抗逆转录病毒疗法治疗HIV相关卡波西肉瘤(SCART):一项开放标签、多中心I/II期试验

Young, Robin J; Kirkham, Amanda; Savage, Joshua; Gaskell, Charlotte; Johnson, Sarah; Dockrell, David H; Bower, Mark; Westwell, Sarah; Bowman, Christine; Leahy, Michael; Woll, Penella; Billingham, Lucinda

Reversible conjugation of a CBASS nucleotide cyclase regulates bacterial immune response to phage infection

CBASS 核苷酸环化酶的可逆结合调节细菌对噬菌体感染的免疫反应

Larissa Krüger, Laura Gaskell-Mew, Shirley Graham, Sally Shirran, Robert Hertel, Malcolm F White

The city nature challenge: A global citizen science phenomenon contributing to biodiversity knowledge and informing local government practices

城市自然挑战:一项全球公民科学现象,有助于增进生物多样性知识并为地方政府实践提供参考。

Palma, Estibaliz; Mata, Luis; Cohen, Kylie; Evans, Doug; Gandy, Bernard; Gaskell, Nadine; Hatchman, Hiliary; Mezzetti, Anna; Neumann, Deborah; O'Keefe, Jessica; Shaw, Amy; Wells, Millie; Williams, Laurence; Hahs, Amy K

Obesity, Physical Activity, and Cancer Incidence in Two Geographically Distinct Populations; The Gulf Cooperation Council Countries and the United Kingdom-A Systematic Review and Meta-Analysis

肥胖、体力活动与两个地理位置迥异的人群癌症发病率的关系:海湾合作委员会国家和英国——系统评价和荟萃分析

Gaskell, Christine; Lutimba, Stuart; Bendriss, Ghizlane; Aleem, Eiman

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

研究者选择标准疗法与序贯新型疗法治疗复发性滤泡性淋巴瘤(REFRACT):一项多中心、开放标签、随机、II期平台试验的研究方案

McIlroy, Graham; Lax, Siân; Gaskell, Charlotte; Jackson, Aimee; Rhodes, Malcolm; Seale, Tania; Fox, Sonia; Hopkins, Lousie; Okosun, Jessica; Barrington, Sally F; Ringshausen, Ingo; Ramsay, Alan G; Calaminici, Maria; Linton, Kim; Bishton, Mark